These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Warfarin-associated intracerebral hemorrhage is increasing in prevalence in the United States. Liotta EM; Prabhakaran S J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1151-5. PubMed ID: 23287421 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Farraj RS Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy. Gathier CS; Algra A; Rinkel GJ; van der Worp HB Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426 [TBL] [Abstract][Full Text] [Related]
6. Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Yung D; Kapral MK; Asllani E; Fang J; Lee DS; Can J Cardiol; 2012; 28(1):33-9. PubMed ID: 22153256 [TBL] [Abstract][Full Text] [Related]
7. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Rosand J; Eckman MH; Knudsen KA; Singer DE; Greenberg SM Arch Intern Med; 2004 Apr; 164(8):880-4. PubMed ID: 15111374 [TBL] [Abstract][Full Text] [Related]
8. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197 [TBL] [Abstract][Full Text] [Related]
9. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes. Deitelzweig SB; Lin J; Kreilick C; Hussein M; Battleman D Adv Ther; 2010 Sep; 27(9):623-33. PubMed ID: 20680533 [TBL] [Abstract][Full Text] [Related]
10. Evaluation and treatment of patients with suspected normal pressure hydrocephalus on long-term warfarin anticoagulation therapy. Goodwin CR; Kharkar S; Wang P; Pujari S; Rigamonti D; Williams MA Neurosurgery; 2007 Mar; 60(3):497-501; discussion 502. PubMed ID: 17327794 [TBL] [Abstract][Full Text] [Related]
11. A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study. Osaki M; Koga M; Maeda K; Hasegawa Y; Nakagawara J; Furui E; Todo K; Kimura K; Shiokawa Y; Okada Y; Okuda S; Kario K; Yamagami H; Minematsu K; Kitazono T; Toyoda K; J Neurol Sci; 2015 Dec; 359(1-2):72-7. PubMed ID: 26671089 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
13. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics. White RH; McKittrick T; Takakuwa J; Callahan C; McDonell M; Fihn S Arch Intern Med; 1996 Jun; 156(11):1197-201. PubMed ID: 8639014 [TBL] [Abstract][Full Text] [Related]
15. The use of warfarin in Christchurch for the treatment of venous thromboembolism. Egermayer P; Inder A; Town GI N Z Med J; 2001 Jul; 114(1136):336-8. PubMed ID: 11548101 [TBL] [Abstract][Full Text] [Related]
16. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA; Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012 [TBL] [Abstract][Full Text] [Related]
17. Stroke prenotification is associated with shorter treatment times for warfarin-associated intracerebral hemorrhage. Dowlatshahi D; Wasserman JK; Butcher KS; Bernbaum ML; Cwinn AA; Giulivi A; Lang E; Poon MC; Tomchishen-Pope J; Sharma M; Coutts SB Cerebrovasc Dis; 2013; 36(5-6):383-7. PubMed ID: 24248034 [TBL] [Abstract][Full Text] [Related]
18. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. Jacobs LG Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465 [TBL] [Abstract][Full Text] [Related]
19. Thrombomodulin as a marker for bleeding complications during warfarin treatment. Lind M; Boman K; Johansson L; Nilsson TK; Ohlin AK; Birgander LS; Jansson JH Arch Intern Med; 2009 Jul; 169(13):1210-5. PubMed ID: 19597070 [TBL] [Abstract][Full Text] [Related]
20. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]